Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Butzler

Showing results (31-40 of 150) with videos related to

Pageof 15
Sort By:
The Journal of Antimicrobial Chemotherapy|August 1, 1989
In-vitro evaluation of antibiotic combinations against Campylobacter fetusH Goossens, H Coignau, L Vlaes, et al.
Lancet (London, England)|October 27, 1979
Campylobacter jejuni post-transfusional septicaemiaF Pepersack, T Prigogyne, J P Butzler, et al.
Acta Clinica Belgica|January 1, 1978
Antibody-coated bacteria in urine and serum antibodies in urinary tract infections in children: their value and their interestR Denis, F Demeuter, H Vanachter, et al.
Scandinavian Journal of Infectious Diseases|January 1, 1982
Serum sensitivity of strains isolated and antibodies against O antigen in gram-negative bacteraemiaN Clumeck, M Steens, Y Englert, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1985
In vitro susceptibilities of 25 Giardia lamblia isolates of human origin to six commonly used antiprotozoal agentsB Gordts, W Hemelhof, C Asselman, et al.
Lancet (London, England)|June 19, 1982
Campylobacter enteritis and erythema nodosumM Lambert, E Marion, E Coche, et al.
Lancet (London, England)|April 2, 1983
Brucella melitensis: person-to-person transmission?H Goossens, L Marcelis, P Dekeyser, et al.
Acta Clinica Belgica|January 1, 1981
Evaluation of the in vitro activity of nifuroxazide on enteropathogenic microorganisms: determination of bacteriostatic and bactericidal concentrations and disk susceptibilityR Vanhoof, H Coignau, G Stas, et al.
Lancet (London, England)|April 14, 1979
Cefotaxime and nephrotoxicityN Clumeck, R Vanhoof, Y Vanlaethem, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1984
Comparison between the in-vitro activity of new agents on Pseudomonas aeruginosa isolates from cystic fibrosis patients and other chronic infectionsB Gordts, C Vandenborre, P VanderAuwera, et al.
Pageof 15

Showing results (31-40 of 150) with videos related to

Sort By:
Pageof 15
The Journal of Antimicrobial Chemotherapy|August 1, 1989
In-vitro evaluation of antibiotic combinations against Campylobacter fetusH Goossens, H Coignau, L Vlaes, et al.
Lancet (London, England)|October 27, 1979
Campylobacter jejuni post-transfusional septicaemiaF Pepersack, T Prigogyne, J P Butzler, et al.
Acta Clinica Belgica|January 1, 1978
Antibody-coated bacteria in urine and serum antibodies in urinary tract infections in children: their value and their interestR Denis, F Demeuter, H Vanachter, et al.
Scandinavian Journal of Infectious Diseases|January 1, 1982
Serum sensitivity of strains isolated and antibodies against O antigen in gram-negative bacteraemiaN Clumeck, M Steens, Y Englert, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1985
In vitro susceptibilities of 25 Giardia lamblia isolates of human origin to six commonly used antiprotozoal agentsB Gordts, W Hemelhof, C Asselman, et al.
Lancet (London, England)|June 19, 1982
Campylobacter enteritis and erythema nodosumM Lambert, E Marion, E Coche, et al.
Lancet (London, England)|April 2, 1983
Brucella melitensis: person-to-person transmission?H Goossens, L Marcelis, P Dekeyser, et al.
Acta Clinica Belgica|January 1, 1981
Evaluation of the in vitro activity of nifuroxazide on enteropathogenic microorganisms: determination of bacteriostatic and bactericidal concentrations and disk susceptibilityR Vanhoof, H Coignau, G Stas, et al.
Lancet (London, England)|April 14, 1979
Cefotaxime and nephrotoxicityN Clumeck, R Vanhoof, Y Vanlaethem, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1984
Comparison between the in-vitro activity of new agents on Pseudomonas aeruginosa isolates from cystic fibrosis patients and other chronic infectionsB Gordts, C Vandenborre, P VanderAuwera, et al.
Pageof 15